Impact of cyclophosphamide and etoposide on outcome of clear cell sarcoma of the kidney treated on the National Wilms Tumor Study-5 (NWTS-5)

Author:

Seibel Nita L.12ORCID,Chi Yueh-Yun3,Perlman Elizabeth J.4,Tian Jing3,Sun Junfeng5,Anderson James R.6,Ritchey Michael L.7,Thomas Patrick R.8,Miser James9,Kalapurakal John A.10,Grundy Paul E.11,Green Daniel M.12

Affiliation:

1. Cancer Therapy Evaluation Program; National Cancer Institute; Bethesda Maryland

2. George Washington University School of Medicine and Health Science; Washington District of Columbia

3. Department of Biostatistics; University of Florida; Gainesville Florida

4. Ann & Robert H. Lurie Children's Hospital; Chicago Illinois

5. Critical Care Medicine Department; Clinical Center; National Institutes of Health; Bethesda Maryland

6. Merck Research Laboratories-Oncology; North Wales Pennsylvania

7. Phoenix Children's Hospital; Phoenix Arizona

8. Temple University Hospital; Philadelphia Pennsylvania

9. City of Hope National Medical Center; Duarte California

10. Lurie Comprehensive Cancer Center of Northwestern University; Chicago Illinois

11. Department of Pediatrics and Oncology; University of Alberta; Edmonton Alberta Canada

12. Department of Epidemiology and Cancer Control; St Jude Children's Research Hospital; Memphis Tennessee

Funder

Children's Oncology Group

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3